http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009045041-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69b4de7d64ebafc368b849bca94eab18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b72af8a65756012bced0aebf43b21bb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b49dfd33b2eb1af6181b78c3c4271a8 |
| publicationDate | 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009045041-A |
| titleOfInvention | Screening method for colorectal cancer preventive substances |
| abstract | 【Task】 Provided is a screening method for a substance effective in preventing cancer, particularly colorectal cancer. [Solution] An object of the present invention is to administer a test substance to a rat, and to express mRNA expression levels of TFF2 protein, PITX2 protein, REG4 protein, ABCA12 protein, LOC689116 protein, FABP1 protein, REG3G protein, PRLPM protein, and PAP protein in colon tissue Can be solved by screening a substance whose expression level is reduced. It is possible to prevent colorectal cancer by ingesting the compound obtained by this method. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016188310-A |
| priorityDate | 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 244.